Rovin Capital UT ADV lowered its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 9.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,582 shares of the biotechnology company’s stock after selling 165 shares during the period. Rovin Capital UT ADV’s holdings in Biogen […]